Meridian Bioscience Cash on Hand 2006-2019 | VIVO

Meridian Bioscience cash on hand from 2006 to 2019. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Meridian Bioscience Annual Cash on Hand
(Millions of US $)
2019 $62
2018 $60
2017 $57
2016 $47
2015 $50
2014 $43
2013 $44
2012 $32
2011 $24
2010 $38
2009 $61
2008 $49
2007 $49
2006 $40
2005 $33
Meridian Bioscience Quarterly Cash on Hand
(Millions of US $)
Q4 2019 $62
Q3 2019 $55
Q2 2019 $66
Q1 2018 $62
Q4 2018 $60
Q3 2018 $58
Q2 2018 $56
Q1 2017 $55
Q4 2017 $57
Q3 2017 $55
Q2 2017 $55
Q1 2016 $49
Q4 2016 $47
Q3 2016 $46
Q2 2016 $49
Q1 2015 $53
Q4 2015 $50
Q3 2015 $46
Q2 2015 $43
Q1 2014 $50
Q4 2014 $43
Q3 2014 $39
Q2 2014 $38
Q1 2013 $44
Q4 2013 $44
Q3 2013 $40
Q2 2013 $39
Q1 2012 $33
Q4 2012 $32
Q3 2012 $28
Q2 2012 $24
Q1 2011 $26
Q4 2011 $24
Q3 2011 $26
Q2 2011 $28
Q1 2010 $41
Q4 2010 $38
Q3 2010 $58
Q2 2010 $61
Q1 2009 $67
Q4 2009 $61
Q3 2009 $53
Q2 2009 $48
Q1 2008 $50
Q4 2008 $49
Q3 2008 $47
Q2 2008 $45
Q1 2007 $54
Q4 2007 $49
Q3 2007 $46
Q2 2007 $40
Q1 2006 $42
Q4 2006 $40
Q3 2006 $36
Q2 2006 $31
Q1 2005 $33
Q4 2005 $33
Q3 2005 $4
Q2 2005 $4
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.395B $0.201B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.160B 27.39
Medtronic (MDT) Ireland $149.747B 20.69
Stryker (SYK) United States $74.065B 24.90
Boston Scientific (BSX) United States $61.077B 28.83
Baxter (BAX) United States $42.381B 25.70
Essilor Luxottica (ESLOY) France $33.712B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.238B 18.97
Terumo (TRUMY) Japan $26.963B 33.65
Lonza Group Ag (LZAGY) Switzerland $25.222B 0.00
Coloplast (CLPBY) Denmark $24.840B 38.33
ResMed (RMD) United States $21.637B 39.92
Smith & Nephew SNATS (SNN) United Kingdom $19.607B 0.00
Sunny Optical Technology (SNPTF) China $19.217B 0.00
Insulet (PODD) United States $11.140B 529.97
Bio-Rad Laboratories (BIO) United States $10.533B 50.56
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Perrigo (PRGO) Ireland $7.324B 13.66
Hill-Rom Holdings (HRC) United States $7.238B 21.34
Canopy Growth (CGC) Canada $7.058B 0.00
Haemonetics (HAE) United States $5.958B 40.26
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.840B 30.24
ICU Medical (ICUI) United States $3.692B 24.07
Neogen (NEOG) United States $3.546B 59.33
GW Pharmaceuticals (GWPH) United Kingdom $3.178B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.061B 0.00
Quidel (QDEL) United States $2.984B 28.32
Aurora Cannabis (ACB) Canada $2.669B 0.00
Agios Pharmaceuticals (AGIO) United States $2.596B 0.00
National Vision Holdings (EYE) United States $2.423B 54.70
Cardiovascular Systems (CSII) United States $1.542B 0.00
InMode (INMD) Israel $1.364B 0.00
Aphria (APHA) $1.230B 0.00
AtriCure (ATRC) United States $1.218B 0.00
VAREX IMAGING (VREX) United States $1.182B 23.68
Phibro Animal Health (PAHC) United States $0.986B 18.46
NanoString Technologies (NSTG) United States $0.908B 0.00
TG Therapeutics (TGTX) United States $0.890B 0.00
Lantheus Holdings (LNTH) United States $0.803B 20.07
Eagle Pharmaceuticals (EGRX) United States $0.803B 30.76
Quanterix (QTRX) United States $0.704B 0.00
LeMaitre Vascular (LMAT) United States $0.697B 39.17
PetIQ (PETQ) United States $0.695B 16.97
Omeros (OMER) United States $0.662B 0.00
HEXO (HEXO) $0.563B 0.00
Cerus (CERS) United States $0.540B 0.00
Surmodics (SRDX) United States $0.532B 55.32
OraSure Technologies (OSUR) United States $0.485B 29.07
MacroGenics (MGNX) United States $0.474B 0.00
Owens & Minor (OMI) United States $0.445B 16.47
Organigram Holdings (OGI) Canada $0.400B 0.00
Utah Medical Products (UTMD) United States $0.388B 28.08
BioLife Solutions (BLFS) United States $0.309B 125.75
Zynex (ZYXI) United States $0.293B 33.19
Bovie Medical (APYX) United States $0.273B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.265B 0.00
United Health Products (UEEC) United States $0.245B 0.00
Viemed Healthcare (VMD) United States $0.244B 25.76
Vapotherm (VAPO) United States $0.244B 0.00
Repro-Med Systems (KRMD) United States $0.239B 0.00
Liberty Health Sciences (LHSIF) Canada $0.179B 0.00
InfuSystems Holdings (INFU) United States $0.164B 824.00
Green Organic Dutchman Holdings (TGODF) Canada $0.160B 0.00
Female Health (VERU) United States $0.159B 0.00
Rockwell Medical (RMTI) United States $0.147B 0.00
MTech Acquisition (KERN) United States $0.132B 0.00
Cytosorbents (CTSO) United States $0.129B 0.00
Fonar (FONR) United States $0.127B 8.98
Chimerix (CMRX) United States $0.116B 0.00
United-Guardian (UG) United States $0.091B 22.91
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Chembio Diagnostics (CEMI) United States $0.076B 0.00
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.063B 0.00
Surface Oncology (SURF) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00